Skip to NavigationSkip to content

Pharmafile - Business Services News

The government has asked for record of as many as 80,000 events
National approvals expected later in the year 
Move follows ban on 350 FDC’s earlier in the week 
Says may be the first applicant for the generic version
To conduct larger scale trial in second half of 2016
The deal is part of Grünenthal's strategy to strengthen position in Latin America
Will reduce interest to 5.1% via a stake sale
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches